Copyright
©The Author(s) 2016.
World J Gastroenterol. Aug 21, 2016; 22(31): 7006-7016
Published online Aug 21, 2016. doi: 10.3748/wjg.v22.i31.7006
Published online Aug 21, 2016. doi: 10.3748/wjg.v22.i31.7006
Figure 2 Balance of apipokine changes involved in the pathogenesis and progression of nonalcoholic fatty liver disease.
NAFLD: Nonalcoholic fatty liver disease; IL-6: Interleukin 6; TNF-α: Tumor necrosis factor-α; RBP4: Retinol-binding protein 4.
- Citation: Abenavoli L, Milic N, Di Renzo L, Preveden T, Medić-Stojanoska M, De Lorenzo A. Metabolic aspects of adult patients with nonalcoholic fatty liver disease. World J Gastroenterol 2016; 22(31): 7006-7016
- URL: https://www.wjgnet.com/1007-9327/full/v22/i31/7006.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i31.7006